BCM
ESPR

Bridgeway Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bridgeway Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-37,000
Closed -$248K – 1398
2022
Q3 		$248K Sell
37,000
-70,000
-65% -$481K 0.01% 1092
2022
Q2 		$681K Hold
107,000
– – 0.02% 808
2022
Q1 		$496K Buy
+107,000
New +$459K 0.01% 939
2015
Q2 		– Sell
-15,200
Closed -$1.41M – 1503
2015
Q1 		$1.41M Sell
15,200
-17,000
-53% -$1.1M 0.03% 657
2014
Q4 		$1.3M Sell
32,200
-3,300
-9% -$101K 0.03% 686
2014
Q3 		$868K Buy
35,500
+9,800
+38% +$156K 0.02% 806
2014
Q2 		$407K Buy
25,700
+700
+3% +$10.1K 0.01% 1178
2014
Q1 		$378K Buy
+25,000
New +$388K 0.01% 1191

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return